- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04786639
Surgical Fixation and Non-Operative Management Outcomes in Proximal Humerus Fractures
Comparison of Surgical Fixation and Non-Operative Management Outcomes in Proximal Humerus Fractures
The management of proximal humerus fractures (PHFs) remains a significant challenge in orthopaedics. The acute treatment options for PHFs are numerous and are typically guided by the fracture pattern and functional demands of the patients. The most commonly used methods include non-operative management with a sling or surgical fixation. Although non-surgical treatment is a reasonable treatment option for the majority of humerus fractures, there is an increasing interest in surgical intervention. There are no evidence-based treatment recommendations, thus permitting large local variation in treatment preferences.
There are a number of studies in the literature about how outcome measures of the patients after PHFs management change, but these results generally compare functional results before and after treatment. Misra et al. stated that conservatively managed patients with PHFs have more pain and a poorer range of motion than those managed by either fixation or arthroplasty, while cochrane review stated that surgery is not superior to nonsurgical treatment in most proximal humerus fractures. Jayakumar et al. determined that kinesiophobia is one of the strongest predictors of functional limitation and recovery from a PHF is enhanced by overcoming fears of movement or reinjury within a week after injury.
There is no clear knowledge regarding how the surgical or conservative management used in the management of PHF affects the early results of assessment parameters. The aim of this study was to compare early results of surgical fixation versus non-operative management outcomes in patients with proximal humerus fractures.
Study Overview
Status
Conditions
Detailed Description
Voluntary patients who have been diagnosed with proximal humerus fracture and managed by surgical or conservative will be included in the study.
Patients with stabilization after proximal humerus fracture with surgical fixation will be considered as the Surgery group, and patients treated with non-surgical treatment with sling immobilization will be considered as the Conservative group. Signed voluntary consent will be obtained from participants. Patients having surgical fixation or nonoperative management will be assessed for kinesiophobia, pain, range of motion, functional status, and quality of life.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
İstanbul
-
Küçükçekmece, İstanbul, Turkey
- Ayşe Alpözgen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Stabilization after proximal humerus fracture with surgical fixation (post-op 3-6 weeks) or non-surgical treatment with sling immobilization (callus formation on radiography).
- Volunteer
Exclusion Criteria:
- Malunion tubercle majus,
- Advanced osteoporosis,
- Avascular necrosis of the humeral head,
- Presence of neurological and rheumatologic disease,
- Recurrent infection and open wound-incision in the region,
- Communication problems
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
Surgical Fixation Group
Open reduction with deltopectoral incision and humeral osteosynthesis with anatomic plates and screws will be performed for surgical fixation.
|
|
Non-Operative Group
Non-surgical treatment will be performed with sling immobilization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kinesiophobia
Time Frame: Baseline
|
Tampa kinesiophobia scale will be used for determining of kinesiophobia or fear of movement.The Tampa Scale for Kinesiophobia is a 17 item questionnaire used to assess the subjective rating of kinesiophobia or fear of movement.
The score varies between 17 and high scores indicate an increasing degree of kinesiophobia.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Shoulder Pain
Time Frame: Baseline
|
A Visual Analogue Scale will be used for pain of rest, night and activity.
It is a scale measuring the distance (mm) on the 10-cm line between the "no pain" (0) and and " worst pain (10).
|
Baseline
|
|
Range of Motion
Time Frame: Baseline
|
Shoulder flexion, extension, external and internal rotation will be measured by using digital goniometer.
It is a reliable and valid tool for measuring shoulder range of motion in individuals with healthy shoulders.
Increasing the degree is considered as an improvement in the range of motion.
|
Baseline
|
|
Functional Status
Time Frame: Baseline
|
The Disabilities of the Arm, Shoulder and Hand questionnaire will be used for measuring of self-rated upper-extremity disability and symptoms.
The scale score ranging is from 0 (no disability) to 100 (most severe disability).
|
Baseline
|
|
Quality of Life of the patients
Time Frame: Baseline
|
The quality of life will be assessed by using 36-Item Short Form Survey.
The survey has eight sub scaled scores; vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health.
Scores range from 0 - 100 and higher scores shows less disability.
|
Baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ayse Zengin Alpozgen, PhD, Istanbul University - Cerrahpasa (IUC)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IUC1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Proximal Humeral Fracture
-
Massachusetts General HospitalCompletedProximal Humeral FracturesUnited States
-
Peking University People's HospitalUnknown
-
RWTH Aachen UniversityCompletedProximal Humeral FracturesGermany
-
Ain Shams UniversityCompletedProximal Humeral FracturesEgypt
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedHumeral Fracture, Proximal
-
Karolinska InstitutetCompleted
-
Herlev HospitalOdense University Hospital; Zealand University Hospital; Aalborg University HospitalUnknownProximal Humeral FracturesDenmark
-
University of Turin, ItalyRecruitingProximal Humeral FracturesItaly
-
Hospital del MarNot yet recruitingProximal Humeral Fractures, Reverse Shoulder Prostheses, Tuberosities
-
Oslo University HospitalDiakonhjemmet Hospital; Sykehuset Telemark; Helse Forde; Sykehuset Ostfold; Sykehuset... and other collaboratorsCompletedProximal Humeral Fractures, AO/OTA (2007) Group B2 and C2Norway